Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens
- PMID: 24197890
- PMCID: PMC3911423
- DOI: 10.1128/JCM.01249-13
Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens
Abstract
Mycobacterium abscessus, which consists of the two subspecies M. abscessus subspecies abscessus and M. abscessus subspecies bolletii, can produce rough or smooth colony morphologies. Here we analyzed 50 M. abscessus isolates cultured from the respiratory specimens of 34 patients, 28 (82%) of whom had cystic fibrosis (CF), with respect to their colony morphologies and antibiotic susceptibilities. The overall proportions of occurrences of the two morphotypes were similar, with specimens from 50% of the patients showing a rough and 38% showing a smooth morphotype. A total of 12% of the specimens from the patients showed both morphotypes simultaneously. At the subspecies level, the proportions of rough and smooth morphotypes differed substantially; 88% of rough morphotypes belonged to M. abscessus subspecies abscessus, and 85% of smooth morphotypes belonged M. abscessus subspecies bolletii. Inducible clarithromycin resistance due to the Erm(41) methylase, as well as high-level resistance to clarithromycin due to mutations within the rrl gene, occurred independently of the morphotype. The MIC50s of amikacin and cefoxitin were identical for the two morphotypes, whereas the MIC50s of tigecycline were 0.25 μg/ml for the rough morphotype and 2.0 μg/ml for the smooth morphotype. Our results show that the smooth morphotype was more dominant in respiratory specimens from CF patients than previously thought. With respect to resistance, colony morphology did not affect the susceptibility of Mycobacterium abscessus to the first-line antibiotics clarithromycin, amikacin, and cefoxitin.
Figures


Similar articles
-
Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.Microbiol Spectr. 2023 Jun 15;11(3):e0504122. doi: 10.1128/spectrum.05041-22. Epub 2023 May 22. Microbiol Spectr. 2023. PMID: 37212700 Free PMC article.
-
Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.Ann Clin Microbiol Antimicrob. 2023 Sep 21;22(1):87. doi: 10.1186/s12941-023-00637-4. Ann Clin Microbiol Antimicrob. 2023. PMID: 37735687 Free PMC article.
-
Impact of Mycobacteroides abscessus colony morphology on biofilm formation and antimicrobial resistance.Int J Med Microbiol. 2024 Mar;314:151603. doi: 10.1016/j.ijmm.2024.151603. Epub 2024 Jan 18. Int J Med Microbiol. 2024. PMID: 38246090
-
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.Expert Rev Anti Infect Ther. 2016 Dec;14(12):1139-1154. doi: 10.1080/14787210.2016.1238304. Epub 2016 Oct 3. Expert Rev Anti Infect Ther. 2016. PMID: 27690688 Review.
-
Treatment of Mycobacterium abscessus Pulmonary Disease.Chest. 2022 Jan;161(1):64-75. doi: 10.1016/j.chest.2021.07.035. Epub 2021 Jul 24. Chest. 2022. PMID: 34314673 Review.
Cited by
-
The many lives of nontuberculous mycobacteria.J Bacteriol. 2018 Feb 26;200(11):e00739-17. doi: 10.1128/JB.00739-17. Online ahead of print. J Bacteriol. 2018. PMID: 29483164 Free PMC article.
-
Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential.Pathogens. 2025 Jun 11;14(6):582. doi: 10.3390/pathogens14060582. Pathogens. 2025. PMID: 40559590 Free PMC article.
-
Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.mBio. 2021 Mar 30;12(2):e03431-20. doi: 10.1128/mBio.03431-20. mBio. 2021. PMID: 33785625 Free PMC article.
-
GenoType NTM-DR for Identifying Mycobacterium abscessus Subspecies and Determining Molecular Resistance.J Clin Microbiol. 2016 Jun;54(6):1653-1655. doi: 10.1128/JCM.00147-16. Epub 2016 Mar 30. J Clin Microbiol. 2016. PMID: 27030487 Free PMC article.
-
Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus.PeerJ. 2021 Oct 26;9:e12391. doi: 10.7717/peerj.12391. eCollection 2021. PeerJ. 2021. PMID: 34760385 Free PMC article.
References
-
- Olivier KN, Weber DJ, Wallace RJ, Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR. 2003. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167:828–834. 10.1164/rccm.200207-678OC - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases